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PyridostigmineThe increase in acetylcholine yielded by pyridostigmine (PYR), an acetylcholinesterase inhibitor, was evaluated
for its effect on the haemodynamic responses—mean arterial pressure (MAP) and heart rate (HR)—and their
nycthemeral oscillation in mice before and one week after myocardial infarction (MI). Mice were anesthetized
(isoﬂurane), and a telemetry transmitter was implanted into the carotid artery. After 5 days of recovery, the
MAP and HR were recorded for 48 h (10s every 10 min). Following this procedure, mice were submitted to sur-
gery for sham or coronary artery ligation and received drinking water (VEHICLE) with or without PYR. Five days
after surgery, the haemodynamic recordingswere recommenced. Sham surgery combined with VEHICLE did not
affect basal MAP and HR; nevertheless, these haemodynamic parameters were higher during the night, before
and after surgery.MI combinedwith VEHICLE displayed decreasedMAP and increasedHR; these haemodynamic
parameters were also higher during the night, before and after surgery. Sham surgery combined with PYR
displayed similar results for MAP as sham combined with VEHICLE; however, PYR produced bradycardia.
Nevertheless, MI combined with PYR exhibited no change inMAP and HR, but these haemodynamic parameters
were also higher during the night, before and after surgery. Therefore,MI decreasedMAP and increasedHR,while
PYR prevented these alterations. Neither MI nor PYR affected nycthemeral oscillations of MAP and HR. These
ﬁndings indicate that the increase in acetylcholine yielded by PYR protected the haemodynamic alterations
caused by MI in mice, without affecting the nycthemeral haemodynamic oscillations.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
There are abundant reports of the circadian inﬂuence on the expres-
sion and severity of cardiovascular diseases (Bonney et al., 2013; Lefer,
2010; Martino and Sole, 2009; Takeda and Maemura, 2011). However,
the impact of cardiovascular diseases on the nycthemeral, or daily, var-
iation of arterial pressure and heart rate has not been examined inmice,
although huge amounts of data are available in humans (Caruana et al.,
1988; Giles et al., 1996; Shaw et al., 2001) and rats (Zhou et al., 2011).
The reliability of telemetry, as well as its capacity to provide recordings
for long periods, makes it a valuable tool for examining alterations on
nycthemeral variation of cardiovascular parameters in mice subjected
to myocardial infarction (MI). It is of note that alterations onSchool of Medicine of Ribeirão
, SP, Brazil. Tel.: +55 16 3602
.
qually to this work.nycthemeral variation of cardiovascular parameters in mice subjected
to MI have never been investigated in this species using telemetry.
It has been well documented that part of the haemodynamic insta-
bilities associated with MI come from the simultaneous reduction of
parasympathetic and increased sympathetic tone of the heart (Luria
et al., 1993; Valkama et al., 1993; Webb et al., 1972). The association
of sympathetic hyperactivity with cardiac deterioration after MI is
well established and conspicuously examined (Hogarth et al., 2006;
Schwenke et al., 2012). Nevertheless, parasympathetic activation has
complex cardiovascular effects in heart failure, which have gained
attention quite recently (Desai et al., 2011; Olshansky et al., 2008). It
is noteworthy that the inhibition of acetylcholinesterase, mimicking
an increase in parasympathetic function to the heart, may represent a
new therapeutic approach for ischemic heart disease (De La Fuente
et al., 2013; Lataro et al., 2013; Sabbah, 2012; Sabino et al., 2013).
Apropos, cholinesterase inhibitors, such as donepezil, rivastigmine and
galantamine were found to be associated with reduced risks of MI and
death in subjects with Alzheimer's disease, compared with those
patients who had never used cholinesterase inhibitors (Nordström
et al., 2013). Moreover, the acetylcholine released from the vagus
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liver, heart, spleen and gastrointestinal tract will interact with
α-bungarotoxin-sensitive nicotinic receptors (acetylcholine receptor)
on tissues macrophage, which inhibit the release of a number of cyto-
kines, for instance TNF, IL-1 and others, playing a role in inﬂammatory
responses (Tracey, 2002).
Pyridostigmine bromide (PYR) inhibits the hydrolysis of acetylcho-
line by acetylcholinesterase prolonging the availability of acetylcholine
in the peripheral cholinergic nerve endings and thereby increases the
efﬁciency of cholinergic transmission (Taylor, 2001). PYR is a reversible
anticholinesterase agent that does not cross the blood–brain barrier and
acts particularly in the peripheral synaptic cleft (Taylor, 2001). Howev-
er, it has been shown that stressful situations disrupt the blood–brain
barrier (Biancardi et al., 2014), allowing PYR penetration into the
central nervous system (Friedman et al., 1996); these results, however,
have not been reproduced by others (Kant et al., 2001; Servatius et al.,
2000). Therefore, the present study examineswhetherMI, a remarkably
stressful condition, may allow PYR to act by centrally modulating the
haemodynamic nycthemeral oscillation in mice.
Thus, the current study aimed to investigate the effects of MI upon
the alterations of mean arterial pressure (MAP) and heart rate (HR)
and their nycthemeral oscillation in mice before and one week after
MI. Moreover, the beneﬁt of pyridostigmine on MAP and HR, and the
possible modulation of their nycthemeral oscillation in the same time
frame, i.e., before and one week after MI, were also examined.
2. Material and methods
2.1. Animals
Experiments were carried out in male C57/BL6 mice (10–15 weeks of
age, averaging 30 g) supplied by the Animal Facility of theMedical School
of Ribeirão Preto (University of São Paulo, Ribeirão Preto, SP, Brazil). The
mice were fed with standard chow diet and tap water ad libitum and
housed under controlled temperature (22 °C) with a 12 h dark–light
cycle. All procedureswere approvedby the Committee of Ethics in Animal
Research of theMedical School of Ribeirão Preto (University of São Paulo,
Ribeirão Preto, SP, Brazil) [Protocol # 203/2008].
2.2. Telemetry transmitter implantation
Mice were anesthetized with isoﬂurane (5% for induction and
2–2.5% for maintenance) diluted in 100% oxygen. The induction took
place in a plastic chamber and, when an appropriate anesthetic plateau
was achieved, the animalwas put onto the surgical table. The anesthetic
mixture was provided by an isoﬂurane vaporizer (Calibrated Vaporizer
Takaoka, model ISOVAPOR 1224, K. Takaoka Ind. Com. Ltda., São Paulo-
SP, Brasil), which delivered it into a tube coupled to a 3.0-mL syringe
cut in the middle, which works as mask. The animals were equipped
with radio telemeter probes (TA11PA-C10, Data Sciences International,
St. Paul, MN, USA), as described by Butz & Davisson (Butz and
Davisson, 2001). After removing the local fur with a depilatory cream
(Veet hair removal cream, Reckitt Benckiser, Brasil, Ltda.) and
disinfecting the skin, amidline incisionwasmade on the ventral cervical
region and the left carotid artery was isolated by blunt dissection. Then,
the probe of the radio telemeter was inserted into the vessel and the
telemeter device was placed subcutaneously on the right ﬂank through
a tunnel under the skin. The skin was then closed with a 6-0 silk suture.
2.3. Myocardial infarction surgery
MIwas performed as described elsewhere (Salto-Tellez et al., 2004).
Brieﬂy, under the same anesthetic protocol employed in the previous
surgery to keep control over mouse ventilation, a ventral midline skin
incision was made caudally to the larynx to access the trachea; then, a
small incision was made to introduce a 22G intravenous catheter tip(BD Angiocath Becton Dickinson Ind. Cir. Ltda., Juiz de Fora, MG, Brasil)
that was connected to a rodent ventilator (Inspira Advanced Safety
Single Animal Pressure/Volume Controlled Ventilator, Harvard Apparatus,
Holliston, MA, USA). The rodent ventilator took the anesthetic mixture
from the isoﬂurane vaporizer. An 80 μL tidal volume was maintained
at 70 cycles per minute. After opening the 3rd intercostal space, the
heart was visualized, the pericardium gently was removed, and an
occlusion was made on the left anterior descending coronary artery
with 8-0 polypropylene suture, just below the left atrium. The intercos-
tal incisionwas closedwith 6-0 silk suture, and a 21Gneedle attached to
a 3.0-mL syringe was introduced through the closed wound, and the
negative pressure of the thorax was re-established thus avoiding dam-
age to the heart and lungs. Finally, the skin was closed with 6-0 silk
suture. At the end, to prevent eventual infection, 50 μL of a mixture of
penicillin and streptomycin (Pentabiótico Veterinário® Pequeno Porte,
Fort Dodge Saúde Animal, Campinas, SP, Brasil) was administered intra-
muscularly. The infarct was conﬁrmed by post-mortem examination.
In the case of sham surgery, all of the steps were performed except
the left anterior descending artery occlusion. All of the surgical proce-
dures were performed under microscope magniﬁcation (DFZ
MC-A199,DF Vasconcellos S.A.Óptica eMecânica de Alta Precisão, Valença,
RJ, Brasil).
2.4. Experimental protocol
After transmitter implantation, the animals were allowed to recover
for ﬁve days before the basal haemodynamic recording, which was
made over 48 h in a scheduled mode (10s every 10 min), providing
the nycthemeral variation of MAP and HR. Data acquisition was carried
out with the software from Data Sciences International (St. Paul, MN,
USA) at a sample frequency of 500 Hz. On the next day, sham occlusion
of the coronary artery orMI surgerywas performed, and oneweek later
the same protocol was repeated. Right after the surgical procedures, the
mice received daily, by gavage, 3 mg/kg of pyridostigmine bromide
(PYR) (Valeant Farmacêutica do Brasil Ltda, Campinas, SP, Brazil) or vehi-
cle divided into two doses of 1,5 mg/kg dissolved in 150 μL (9:00 a.m.
and 5 p.m.). The dose used in the present study (3 mg/kg/day) has
been demonstrated to decrease blood acetylcholinesterase activity by
85% (Bernatova et al., 2003). The animals were randomly sorted into
four groups: sham that received vehicle (SHAM + VEHICLE; N = 6);
sham that received PYR (SHAM+PYR;N=6);MI that received vehicle
(MI + VEHICLE; N= 6); and MI that received PYR (MI + PYR; N= 6).
The data from the telemetric device were collected by a RPC-1 receiver
placed under themouse cage, using the Dataquest A.R.T system, version
4.2 (Data Sciences International, St Paul,MN, USA).
2.5. Morphological analysis
After the haemodynamic recordings, the animalswere killedwith an
overdose of ketamine (178mg/kg;Ketamina Agener União Saúde Animal,
Embu-Guaçu, SP, Brasil) and xylazine (35 mg/kg; Dopaser® Hertape
Calier Saúde Animal S/A, Juatuba, MG, Brasil) mixture; the hearts were
collected and ﬁxed in phosphate-buffered 10% formalin. To evaluate
the size (%) of the infarcted myocardium, the area stained with
picrosirius red was compared with the total left ventricular circumfer-
ential area. To accomplish this, sections were analyzed using the video
microscopy Leica Qwin (Leica Imaging Systems, Cambridge, UK), and
the infarcted area was measured using NIH ImageJ software.
2.6. Statistical analysis
The results are shown as mean ± S.E.M. (standard error of the
mean). Data were analyzed by linear mixed-effect models which
include a random effect correlating multiple observations of the same
animal during follow-up. These models allowed estimation of MAP
andHR averages for each group, period and time; comparisons between
Fig. 2. Representative tracings of pulsatile arterial pressure (PAP), mean arterial pressure
(white line) and heart rate (HR) from a conscious mouse before and one week after
myocardial infarction.
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contrast. The software SAS version 9.2 was used to ﬁt the model. Differ-
ences were considered signiﬁcant when p b 0.05.
3. Results
3.1. Morphological analysis of the hearts.
Fig. 1 shows the representative picrosirius red stained sections of
hearts from the SHAM + VEHICLE, SHAM + PYR, MI + VEHICLE
and MI + PYR groups. Scarring can be observed in the left ventricles
of MI + VEHICLE and MI + PYR mice, while the SHAM + VEHICLE
and SHAM + PYR groups display normal left ventricle wall thickness
without damage to the myocardium. Morphological analysis revealed
similar infarct size in both myocardial infarcted groups, i.e., 12 ± 2% in
MI + VEHICLE vs. 11 ± 1% in MI + PYR group.
3.2. Haemodynamic characteristics of sham and myocardial infarcted mice
combined with vehicle or pyridostigmine
Fig. 2 shows typical tracings of pulsatile and mean arterial pressure
and HR from conscious mice treated with vehicle, before and 1 week
after myocardial infarction. The MI + VEHICLE group exhibited lower
24 h averaged MAP (97 ± 2 vs. 106 ± 2 mm Hg before, p = 0.041)
and higher 24 h averaged HR (553 ± 10 vs. 475 ± 11 bpm before,
p = 0.002) (Figs. 3 and 4), while PYR prevented these alterations in
the MI + PYR group (101 ± 4 vs. 100 ± 2 mm Hg before; 489 ± 15
vs. 469 ± 12 bpm before, Figs. 3 and 4). The SHAM + VEHICLE group
presented similar results for 24 h averaged MAP (108 ± 2 vs.110 ±
3 mm Hg before) and HR (506 ± 9 vs. 534 ± 8 bpm before), while
SHAM + PYR exhibited similar 24 h averaged MAP (104 ± 3 vs.
102 ± 2 mm Hg before), but lower 24 h averaged HR (490 ± 7 vs.
529 ± 14 bpm before, p= 0.025) (Figs. 3 and 4).
3.3. Nycthemeral variation before and one week after sham surgery or MI
combined with vehicle or pyridostigmine
Before and after sham surgery or MI theMAP (Fig. 2) and HR (Fig. 3)
were signiﬁcantly higher (p b 0.05), during the night in all studied
groups.
4. Discussion
An advantage of radio telemetry is the ability to record physiological
parameters during the entire day, providing an opportunity to reveal
haemodynamic nycthemeral oscillations that would otherwise remain
undetected. The SHAM + VEHICLE group showed higher levels of
MAP and HR during the night, before and after shamMI. These ﬁndings
are consistent with reports from the literature (Butz and Davisson,
2001; Palma-Rigo et al., 2010; Sheward et al., 2010), providing evidence
that the telemetry system used in the present study reliably examined,
in conscious freely moving mice, the haemodynamic oscillations before
and one week after MI.Fig. 1. Representative picrosirius red-stained sections of the hearts of shammyocardial infarcte
dial infarcted mice treated with pyridostigmine (MI + PYR) or vehicle (MI + VEHICLE).The infarct size was similar in the MI + VEHICLE (12 ± 2%) and
MI + PYR (11 ± 1%) groups. Reports of larger lesions in mice have
also been documented. Ligation of the L2 and/or L3 of the left anterior
descending coronary artery branches in mice elicits a reproducible
small (16 ± 3.64%) MI scar (Ahn et al., 2004). In the present study, it
was shown that the ligation immediately below the left atrium may
be responsible for the relatively small size of the resulting scar in MI
+ VEHICLE and MI + PYR groups.
It is noteworthy that even a small (11% to 12%) MI in mice was able
to produce a fall inMAP as well as an increase in HR. This increase in HR
differs from the literature, which has shown no change of HR after MI in
mice (DeWaard et al., 2007; Ferferieva et al., 2012; Hoefer et al., 2010;
Matsusaka et al., 2006; Odashima et al., 2007; Virag et al., 2010). Never-
theless, there is only one report of no change in HR recorded by means
of telemetry (Infanger et al., 2010); however, these data were collected
two weeks after MI (Infanger et al., 2010), rather than the one week
protocol used in the present study.
Signiﬁcant decrease of MAP was observed following MI. The data
regarding changes of arterial pressure after MI are quite variable.
There are reports of signiﬁcant decrease of arterial pressure in myocar-
dial infarcted mice (Arikawa et al., 2011; Hoefer et al., 2010; Infanger
et al., 2010; Odashima et al., 2007; Westermann et al., 2008), but
there are also reports of no change when the arterial pressure was
assessed directly (De Waard et al., 2007) or by the tail cuff method
(Bove et al., 2004; Hanatani et al., 2012; Liu et al., 2002). It is understood
that the methodological approach for recording the arterial pressure,
i.e., direct (intra-arterial cannula), indirect (tail cuff), or even the format
of the protocol applied for telemetrymay have a signiﬁcant inﬂuence on
the levels of the arterial pressure recorded in mice after MI.
It was observed that PYR was effective in preventing the decrease in
MAP as well as the increase in HR one week following MI. Alternativelydmice treated pyridostigmine (SHAM+ PYR) or vehicle (SHAM+VEHICLE) andmyocar-
Fig. 3.Mean arterial pressure (MAP) from sham and myocardial infarcted mice, recorded during the day and the night, before and after sham surgery or coronary artery ligation. The
groups were treated with vehicle (SHAM + VEHICLE, n = 6 and MI + VEHICLE, n = 6) or pyridostigmine (SHAM + PYR, n = 6 and MI + PYR, n = 6). Data are the mean ± SEM.
*p b 0.05 comparing day versus night. # p b 0.05 comparing before versus after.
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ase may also enhance sympathetic drive to blood vessels by facilitating
ganglionic neurotransmission,which is also cholinergic. It is of note that
previous clinical observations (Singer et al., 2006) have demonstrated
that pyridostigmine signiﬁcantly improved standing arterial pressure
in patients with orthostatic hypotension—a condition of sympathetic
overactivity—without worsening supine hypertension—a condition of
low sympathetic activity. Because pyridostigmine exhibited a greater
effect on standing diastolic arterial pressure, this ﬁnding suggested
that this improvement was due to increased total peripheral resistanceFig. 4.Heart rate (HR) from sham andmyocardial infarctedmice, recorded during the day and th
with vehicle (SHAM+VEHICLE,n=6andMI+VEHICLE,n=6)or pyridostigmine (SHAM+P
night. # p b 0.05 comparing before versus after.(Singer et al., 2006). Therefore, mice under sympathetic overactivity
due to MI may have beneﬁted from the ganglionic effect of
pyridostigmine, which augmented the sympathetic drive to resistant
vessels preventing the fall in arterial pressure caused byMI. Concerning
the protective effect of PYR on HR, this ﬁnding is consistent with obser-
vations from our laboratory that PYR increases parasympathetic activity
fourweeks afterMI inmice (Durand et al, 2014). Therefore, thepharma-
cological effect of PYRmight be attributed to the inhibition of acetylcho-
linesterase, with consequent accumulation of endogenous acetylcholine
in the vicinity of the nerve endings in the heart, producing effectse night, before and after sham surgery or coronary artery ligation. The groupswere treated
YR, n=6andMI+PYR, n=6). Data are themean±SEM. *p b 0.05 comparing day versus
54 W.G. Corrêa et al. / Autonomic Neuroscience: Basic and Clinical 187 (2015) 50–55similar to vagal nerve stimulation, e.g. bradycardia (Desai et al., 2011;
Taylor, 2001).
Higher levels of MAP and HR were observed in all of the groups
during the night comparedwith the values recorded during the day, be-
fore and after sham or MI. It has been well-documented that higher
levels of haemodynamic oscillations are present in a conscious state
(Su et al., 2008), which in mice is represented by the nocturnal period
(Bray et al., 2008). The results of nycthemeral oscillations found in the
current study are consistent with the studies carried out in mice
mentioned above (Bray et al., 2008; Su et al., 2008).
It is of note that the impact of MI on the nycthemeral variation of
MAP and HR has never been examined inmice until now, since patients
with chronic heart failure frequently show blunted circadian blood
pressure proﬁles (Portaluppi et al, 2012). The lack of effect of MI upon
the normal haemodynamic nycthemeral rhythmicity in both myocardi-
al infarcted groupsmight be attributed to the smallmagnitude of theMI
(11% to 12%). AlthoughOhori et al. (2011) examined this issue in anoth-
er species, they observed no impairment of the circadian rhythms in
MAP and HR, three weeks after MI in congestive heart failure rats with
an infarct size of 34%. Therefore, the small extent of the infarct size
observed in the current study cannot be blamed for the lack of change
of the haemodynamic nycthemeral variation after MI in mice.
PYR did not affect the haemodynamic nycthemeral oscillation in
mice after sham surgery or MI. The ﬁndings from sham surgery are in
line with those from Bernatova et al. (2003) who did not ﬁnd differ-
ences in MAP and HR during the dark and light periods after treatment
with PYR.With respect toMI, to our knowledge, this is theﬁrst time that
the effects of PYR were examined in the haemodynamic nycthemeral
oscillation in myocardial infarcted mice. Taking into account that the
nycthemeral oscillations of MAP and HR were not altered after MI, it is
understood that there was no reason to expect that the increase in
acetylcholine yielded by PYRwould cause any effect on these haemody-
namic nycthemeral oscillations.5. Conclusion
MI decreased MAP and increased HR, while PYR prevented these
alterations. Neither MI nor PYR affected the nycthemeral oscillation of
MAP and HR. These ﬁndings indicate that the increase in acetylcholine
yielded by PYR protected the haemodynamic alterations caused by MI
in mice, without affecting the nycthemeral haemodynamic oscillations.Acknowledgments
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